title: Revitalizing personalized medicine: respecting biomolecular complexities beyond gene expression.
abstract: Despite recent advancements in "omic" technologies, personalized medicine has not realized its fullest potential due to isolated and incomplete application of gene expression tools. In many instances, pharmacogenomics is being interchangeably used for personalized medicine, when actually it is one of the many facets of personalized medicine. Herein, we highlight key issues that are hampering the advancement of personalized medicine and highlight emerging predictive tools that can serve as a decision support mechanism for physicians to personalize treatments.
authors.affiliation: School of Chemical Engineering, Purdue University, West Lafayette, Indianapolis, USA.
authors.forename: D
authors.initials: D
authors.lastname: Jayachandran
authors.affiliation: 2017 Stonebridge Way, Canton, Michigan, USA.
authors.forename: U
authors.initials: U
authors.lastname: Ramkrishna
authors.affiliation: Riley Hospital for Children, Indianapolis, Indianapolis, USA.
authors.forename: J
authors.initials: J
authors.lastname: Skiles
authors.affiliation: Riley Hospital for Children, Indianapolis, Indianapolis, USA.
authors.forename: J
authors.initials: J
authors.lastname: Renbarger
authors.affiliation: School of Chemical Engineering, Purdue University, West Lafayette, Indianapolis, USA.
authors.forename: D
authors.initials: D
authors.lastname: Ramkrishna
references.citation: N Engl J Med. 2013 Dec 12;369(24):2273-5
references.pmid: 24328463
references.citation: Pharmacogenetics. 1992 Aug;2(4):148-59
references.pmid: 1306116
references.citation: Curr Drug Metab. 2012 Sep 1;13(7):968-77
references.pmid: 22591349
references.citation: Cancer Cell. 2008 Aug 12;14(2):111-22
references.pmid: 18656424
references.citation: Science. 1999 Oct 15;286(5439):531-7
references.pmid: 10521349
references.citation: Mol Syst Biol. 2010 Sep 7;6:401
references.pmid: 20823844
references.citation: Pharmacotherapy. 2008 Aug;28(8):992-8
references.pmid: 18657016
references.citation: Pharmacogenet Genomics. 2005 May;15(5):365-9
references.pmid: 15864139
references.citation: Curr Opin Chem Biol. 2009 Dec;13(5-6):556-61
references.pmid: 19833543
references.citation: Eur J Clin Pharmacol. 1993;44(2):147-52
references.pmid: 8453958
references.citation: Wiley Interdiscip Rev Syst Biol Med. 2009 Nov-Dec;1(3):285-297
references.pmid: 20835998
references.citation: Environ Health Perspect. 2003 Aug;111(11):A581-9
references.pmid: 12928155
references.citation: Eur J Clin Pharmacol. 2010 Aug;66(8):749-54
references.pmid: 20563567
references.citation: J Surg Oncol. 1998 Jun;68(2):70-8
references.pmid: 9624035
references.citation: Clin Pharmacol Ther. 1983 Dec;34(6):810-7
references.pmid: 6580097
references.citation: Cell. 2012 Jul 20;150(2):389-401
references.pmid: 22817898
references.citation: Nature. 2000 Feb 3;403(6769):503-11
references.pmid: 10676951
references.citation: Nat Rev Genet. 2005 Jun;6(6):451-64
references.pmid: 15883588
references.citation: Clin Pharmacol Ther. 2012 Jul;92(1):50-61
references.pmid: 22644330
references.citation: Eur J Gastroenterol Hepatol. 2004 Jul;16(7):705-10
references.pmid: 15201586
references.citation: J Comput Biol. 2000;7(3-4):601-20
references.pmid: 11108481
references.citation: Ann Clin Biochem. 2013 Nov;50(Pt 6):523-45
references.pmid: 23888060
references.citation: Am J Pharmacogenomics. 2003;3(6):361-70
references.pmid: 14672516
references.citation: Pharmacogenomics J. 2006 Jan-Feb;6(1):16-21
references.pmid: 16302022
references.citation: Cancer Res. 2008 Feb 1;68(3):650-6
references.pmid: 18245463
references.citation: Cancer Res. 1996 Dec 15;56(24):5754-7
references.pmid: 8971187
references.citation: Clin Pharmacol Ther. 1989 Aug;46(2):149-54
references.pmid: 2758725
references.citation: Semin Nephrol. 2010 Sep;30(5):500-11
references.pmid: 21044761
references.citation: Clin Pharmacol Ther. 1987 Jan;41(1):18-25
references.pmid: 3467886
references.citation: J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):192-9
references.pmid: 11297331
references.citation: Nat Rev Genet. 2006 Feb;7(2):85-97
references.pmid: 16418744
references.citation: Nat Rev Mol Cell Biol. 2011 Feb;12(2):119-25
references.pmid: 21224886
references.citation: Nature. 2006 Apr 20;440(7087):1073-7
references.pmid: 16625200
references.citation: Nature. 2010 Jun 10;465(7299):736-45
references.pmid: 20535203
references.citation: Annu Rev Pharmacol Toxicol. 2001;41:101-21
references.pmid: 11264452
references.citation: Biotechnol Bioeng. 2008 Jun 15;100(3):542-59
references.pmid: 18438875
references.citation: Pediatr Blood Cancer. 2008 Apr;50(4):769-71
references.pmid: 18085684
references.citation: N Engl J Med. 2013 Dec 12;369(24):2283-93
references.pmid: 24251361
references.citation: Biotechnol Bioeng. 2011 Jan;108(1):127-40
references.pmid: 20830732
references.citation: Genome Res. 2002 Nov;12(11):1687-92
references.pmid: 12421755
references.citation: Science. 2005 Mar 25;307(5717):1965-9
references.pmid: 15790857
references.citation: Mol Syst Biol. 2006;2:2006.0033
references.pmid: 16773083
references.citation: N Engl J Med. 1998 Mar 5;338(10):640-4
references.pmid: 9486992
references.citation: Stem Cells. 1998;16(6):413-28
references.pmid: 9831867
references.citation: FEBS Lett. 2005 Mar 21;579(8):1834-8
references.pmid: 15763560
references.citation: J Proteome Res. 2004 Mar-Apr;3(2):179-96
references.pmid: 15113093
references.citation: Cell. 2004 Sep 17;118(6):675-85
references.pmid: 15369668
references.citation: PLoS Comput Biol. 2012;8(10):e1002750
references.pmid: 23133351
references.citation: Cell. 2010 May 14;141(4):583-94
references.pmid: 20478252
references.citation: Leukemia. 2009 Mar;23(3):557-64
references.pmid: 18987654
references.citation: Science. 2011 May 6;332(6030):687-96
references.pmid: 21551058
references.citation: Hematology Am Soc Hematol Educ Program. 2006;:111-7
references.pmid: 17124048
references.citation: Nat Biotechnol. 2008 Sep;26(9):1003-10
references.pmid: 18711341
references.citation: Nature. 2009 May 21;459(7245):428-32
references.pmid: 19363473
references.citation: J Natl Cancer Inst. 2007 Oct 3;99(19):1441-54
references.pmid: 17895480
references.citation: Pharmacogenomics. 2011 Jan;12(1):103-11
references.pmid: 21174625
references.citation: Science. 2008 Aug 22;321(5892):1081-4
references.pmid: 18719282
references.citation: Science. 1999 Oct 15;286(5439):487-91
references.pmid: 10521338
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1933-8
references.pmid: 15671173
references.citation: N Engl J Med. 2013 Dec 12;369(24):2345-6
references.pmid: 24251364
references.citation: PLoS Comput Biol. 2011 Aug;7(8):e1002140
references.pmid: 21901083
references.citation: Genet Epidemiol. 1995;12(1):1-11
references.pmid: 7713396
references.citation: JAMA. 1998 Apr 15;279(15):1200-5
references.pmid: 9555760
references.citation: Nature. 2001 Feb 15;409(6822):860-921
references.pmid: 11237011
references.citation: Mol Syst Biol. 2010 Sep 7;6:411
references.pmid: 20823849
references.citation: J Rheumatol. 1995 May;22(5):844-9
references.pmid: 8587070
references.citation: Cell Mol Life Sci. 2008 Oct;65(20):3145-67
references.pmid: 18581055
references.citation: Br J Clin Pharmacol. 2013 Jul;76(1):125-36
references.pmid: 23252716
references.citation: Nat Clin Pract Oncol. 2009 Jan;6(1):34-42
references.pmid: 18852721
references.citation: Genome Res. 2003 Nov;13(11):2396-405
references.pmid: 14597654